NorthWest Biotherapeutics Inc (NWBO)

[MI Dendream]

Senti, I previously had your vote down for “B” but now it seems you’ve shifted to “A”. I vote for “D” as well as Flipper, CassieW, and it seems Biosect. Everyone has their own opinion here, and mine may not be right. Although everyone is entitled to an opinion, only one of the below answers is correct and we do not decide…FDA decides.

Multiple choice question, which possibility makes the most sense:
A - FDA allows you to market your product before approval at any time as long as you call it a platform technology or use a temporary Brand Name.
B - Avoiding premarket promotion penalties is as easy as dropping the L off the end of your trademarked Branded product name
C - Advertisement only counts if it is on something that I personally deem valuable
D - FDA only allows you to premarket promote using very specific guidelines and only within 6 months of certain approval and does not care what channel you utilize

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=166859832